Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

CNY 7.72

(-0.64%)

Total Debt Summary of Sichuan Goldstone Asia Pharmaceutical Inc.

  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest annual total debt in 2023 was 114.82 Million CNY , up 1013.4% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest quarterly total debt in 2024 Q2 was 28.48 Million CNY , down -76.5% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported annual total debt of 10.31 Million CNY in 2022, up 952.2% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported annual total debt of 980.16 Thousand CNY in 2021, down -90.2% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported quarterly total debt of 25.02 Million CNY for 2024 Q3, down -7.17% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported quarterly total debt of 28.48 Million CNY for 2024 Q2, down -76.5% from previous quarter.

Annual Total Debt Chart of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Historical Annual Total Debt of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 114.82 Million CNY 1013.4%
2022 10.31 Million CNY 952.2%
2021 980.16 Thousand CNY -90.2%
2020 10 Million CNY 25.0%
2019 8 Million CNY -68.0%
2018 25 Million CNY -65.75%
2017 73 Million CNY 0.0%
2016 - CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%
2013 - CNY 0.0%
2012 - CNY -100.0%
2011 14 Million CNY 0.0%

Peer Total Debt Comparison of Sichuan Goldstone Asia Pharmaceutical Inc.

Name Total Debt Total Debt Difference
China National Complete Plant Import & Export Corporation Limited 917.68 Million CNY 87.487%